These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 23927683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH, Smith PW.
    Bioorg Med Chem; 2015 Aug 15; 23(16):5087-97. PubMed ID: 25577708
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 15; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In silico analyses for the discovery of tuberculosis drug targets.
    Chung BK, Dick T, Lee DY.
    J Antimicrob Chemother; 2013 Dec 15; 68(12):2701-9. PubMed ID: 23838951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improving the tuberculosis drug development pipeline.
    Evangelopoulos D, McHugh TD.
    Chem Biol Drug Des; 2015 Nov 15; 86(5):951-60. PubMed ID: 25772393
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 15; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Computational medicinal chemistry for rational drug design: Identification of novel chemical structures with potential anti-tuberculosis activity.
    Koseki Y, Aoki S.
    Curr Top Med Chem; 2014 Sep 15; 14(1):176-88. PubMed ID: 24236720
    [Abstract] [Full Text] [Related]

  • 14. The future for early-stage tuberculosis drug discovery.
    Zuniga ES, Early J, Parish T.
    Future Microbiol; 2015 Sep 15; 10(2):217-29. PubMed ID: 25689534
    [Abstract] [Full Text] [Related]

  • 15. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS, Rather MA, Maqbool M, Ahmad Z.
    Biomed Pharmacother; 2018 Jul 15; 103():1733-1747. PubMed ID: 29864964
    [Abstract] [Full Text] [Related]

  • 16. Challenges and opportunities in developing novel drugs for TB.
    Kaneko T, Cooper C, Mdluli K.
    Future Med Chem; 2011 Sep 15; 3(11):1373-400. PubMed ID: 21879843
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increasing the structural coverage of tuberculosis drug targets.
    Baugh L, Phan I, Begley DW, Clifton MC, Armour B, Dranow DM, Taylor BM, Muruthi MM, Abendroth J, Fairman JW, Fox D, Dieterich SH, Staker BL, Gardberg AS, Choi R, Hewitt SN, Napuli AJ, Myers J, Barrett LK, Zhang Y, Ferrell M, Mundt E, Thompkins K, Tran N, Lyons-Abbott S, Abramov A, Sekar A, Serbzhinskiy D, Lorimer D, Buchko GW, Stacy R, Stewart LJ, Edwards TE, Van Voorhis WC, Myler PJ.
    Tuberculosis (Edinb); 2015 Mar 15; 95(2):142-8. PubMed ID: 25613812
    [Abstract] [Full Text] [Related]

  • 19. Next-generation antimicrobials: from chemical biology to first-in-class drugs.
    Ang ML, Murima P, Pethe K.
    Arch Pharm Res; 2015 Sep 15; 38(9):1702-17. PubMed ID: 26259630
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.